NCT06504407

Brief Summary

The U.S. population is becoming more diverse, but minority groups are still significantly underrepresented in cancer clinical trials. This disparity limits our understanding of how treatments work across different populations. Efforts like the 21st Century Cures Act aim to improve inclusion, but challenges persist due to historical mistrust and complex barriers in healthcare. To address these issues, Penn State Health is using a fun and educational approach called "BINGO" to engage the African American/Black community in Dauphin and surrounding counties. Led by the PSCI Diversity Navigator, these BINGO games will provide information about cancer and clinical trials in a relaxed setting. The goal is to build trust, increase awareness, and ultimately improve participation of underrepresented groups in clinical trials. Through this initiative, they hope to connect participants with needed healthcare services and gather feedback to tailor future trials to community needs. This approach aims to foster collaboration between minority communities and the healthcare system, ensuring that clinical trials reflect the diversity of the population they aim to serve.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 16, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 28, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 13, 2025

Completed
Last Updated

March 23, 2026

Status Verified

January 1, 2026

Enrollment Period

1.1 years

First QC Date

July 11, 2024

Last Update Submit

March 18, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility Measure

    Percentage of Participants Attending a Complete Bingo Game Session and Completing Pre- and Post-Test Surveys.

    one year

  • Utility Measure

    Pre- and post-test scores on knowledge-based questions will be compared to measure the effectiveness of the educational content.

    one year

  • Engagement Measure

    Participant engagement will be evaluated using a 5-point Likert scale, with the percentage of participants who "strongly agree or agree" that Bingo game was engaging being the primary measure.

    one year

Study Arms (1)

Bingo Educational Intervention

EXPERIMENTAL

Single-arm, interventional study where all participants will engage in the Bingo game as an educational intervention.

Behavioral: Bingo Educational Game

Interventions

The intervention involves Bingo games designed to educate African American/Black community members about cancer and clinical trials. During each game, educational facts are shared, and prizes promoting healthy lifestyles are awarded. Led by a Diversity Navigator, the sessions include pre- and post-test surveys to assess knowledge gain and engagement. The intervention also connects participants with needed medical services.

Bingo Educational Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Adults aged 18 years and above.
  • Gender Identity: Individuals identifying as cisgender, transgender, or females.
  • Language Proficiency: Proficiency in English equivalent to middle school/high school level.
  • Registration: Completion of registration via the provided RedCap link prior to the Bingo session.
  • Consent: Willingness to provide written consent at the beginning of the Bingo session to participate in the research study.

You may not qualify if:

  • Age: Individuals under the age of 18 years.
  • Gender Identity: Participants who do not identify as cisgender, transgender, or females.
  • Language Proficiency: Inability to understand English at a middle school/high school level.
  • Previous Participation: Individuals who have already participated in a previous Bingo game session for this study.
  • Medical or Cognitive Impairment: Participants unable to provide informed consent or actively participate due to medical or cognitive reasons.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn State Cancer Institute

Hershey, Pennsylvania, 17033, United States

Location

Study Officials

  • Monali Vasekar, MD

    Penn State Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: Single arm interventional study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 16, 2024

Study Start

October 28, 2024

Primary Completion

December 13, 2025

Study Completion

December 13, 2025

Last Updated

March 23, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Information will be collected in De identified manner . IPD will not be shared with any other researchers.

Locations